Frederick Garland, DPM
Podiatrist · Longs, SCNPI 1467989632
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,600 of the $5,268 with a category attached, or 68.3%. 5 manufacturers reported payments, led by Arthrex at 53.0% of the total. Reporting peaked in 2021 at $5,111 and has fallen 99.2% since, to $38 in 2023.
Across 24 payments — averaging $219.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Peerless Surgical Inc.$2K
- Medtronic$118
- Amgen$19
- Averitas Pharma Inc.$19
What the payments were for
- Travel & lodging$80715%
- Food & beverage$86116%
- Education$3,60068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 11 | $2,793 |
| Peerless Surgical Inc. | 10 | $2,319 |
| Medtronic | 1 | $118 |
| Amgen | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJEX$118
How this compares
$5,268 in reported general payments places this provider in the 85th percentile of 61 podiatrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 35 | $1,005 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $334 |
| Terbinafine Hcl | 20 | $321 |
| Cephalexin | 20 | $283 |
| Doxycycline Hyclate | 12 | $125 |
| Methylprednisolone | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Longs
- Brandon PercivalLancaster$136K
- Alan BlockFlorence$96K
- William LongSimpsonville$91K
- Michael McCannFlorence$15K
- Daniel MethuselahIrmo$14K
- Breelyn MilesLadson$13K
- Jeffrey YungHilton Head Island$11K
- Arthur StoneGreenville$11K
- Jamelah LemonMauldin$6K
- Anila RafiqCharleston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.